"Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials"
In recent years, GLP-1 receptor agonists first developed as diabetes medications exploded in popularity after researchers discovered they could also dramatically improve weight loss
Based on this, Eng understood the importance of maintaining glucose levels in diabetic patients to prevent them suffering complications like blindness, nerve damage and kidney failure (Toiv)
Semaglutide pens come in different doses, from 0.25 mg to 2.4 mg, and which one you get will depend on what dosage your healthcare provider prescribes for you
NICE technology appraisal TA875 (2023) recommends Wegovy within a specialist weight management service for adults with a BMI of 35 kg/m or above (or 30 kg/m in certain high-risk groups) and at least one weight-related health condition, for a maximum of two years